-
Michael Bloomberg Fights Big Tobacco in Uruguay
Michael Bloomberg is a man on a mission. This, of course, isn't the first "noble cause" he's latched on to but the "evil" of tobacco is something he feels particularly strongly about.
- Categories
- Health Care
-
Budget Cuts and Vaccine Fears Threaten Health Progress
Cuts to global health research budgets and people’s wariness of vaccines could hamper efforts to improve health around the world, two separate reports have warned in the run-up to World Health Day, which is marked today.
- Categories
- Education, Health Care
-
Study: Zambia’s Malaria Success Story Masks Basic Health Failures
A new study reveals that while Zambia has made great progress against malaria over the past decade or so it was losing ground on many other health needs like basic child immunizations and maternal health care.
- Categories
- Health Care
-
Obgyn Training in Sub-Saharan Africa Bolstered By New Collections Shared Both Online and Offline
U-M’s 1000+ OBGYN Project provides free access to educational materials to support ob-gyn training in Africa for improved maternal, newborn care.
- Categories
- Education, Health Care, Technology
- Region
- Sub-Saharan Africa
-
Saving Lives By Making Malaria Drugs More Affordable
Forty percent of all malaria-caused deaths in sub-Saharan Africa occur in the Democratic Republic of Congo and Nigeria, according to the World Health Organization. The private sector "supply chain" manages 74% of the drug volume in Congo and 98% in Nigeria where malaria-stricken patients rely on "drug shops" and other for-profit retail outlets to get life-saving medicine.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Here Are Nine Ways to Deal With Delhi’s Air Pollution—But You May Not Be Able to Afford Any of Them
Delhi’s air pollution hit new highs last winter, giving the city, at least briefly, the worst air quality readings of any place on earth.
- Categories
- Environment, Health Care
- Region
- South Asia
-
New Japanese Encephalitis Vaccine ‘A Historic Moment for Global Health’
As I prepare for retirement this month and reflect on my four years as the director of the neglected infectious diseases team here at the Bill & Melinda Gates Foundation, one of the things I am most proud of is to have been part of a global team that has been working to get a new Japanese encephalitis vaccine to the millions of people who need it.
- Categories
- Health Care
- Region
- Asia Pacific
- Tags
- vaccines
-
Chinese Pharma: A Global Health Game Changer?
The twenty-first century shift in geoeconomic power toward Asia has also spurred a rebalancing in global pharmaceutical research and development (R&D) investment toward emerging economies. China is currently the world’s second-highest investor in R&D and is poised to overtake the United States in R&D spending by 2023. Determined to become a world leader in the pharmaceutical sector, China spent $1.17 billion on promoting life and medical sciences in 2012—nearly ten times its 2004 level of investment. With U.S. funding for medical research on the decline, the surge in Chinese funding has prompted many policymakers to ask if the country's pharmaceutical industry could be the next game changer for global public health and access to medicine (ATM).
- Categories
- Education, Health Care
- Region
- South Asia
- Tags
- research
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.